FC
BSX icon

Fairpointe Capital’s Boston Scientific BSX Stock Holding History

Fairpointe Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-12,400
Closed -$290K – 79
2016
Q2 		$290K Sell
12,400
-37,450
-75% -$810K 0.01% 76
2016
Q1 		$938K Sell
49,850
-11,800
-19% -$207K 0.02% 68
2015
Q4 		$1.14M Sell
61,650
-2,300
-4% -$41.2K 0.02% 65
2015
Q3 		$1.05M Sell
63,950
-1,300
-2% -$22.2K 0.02% 66
2015
Q2 		$1.16M Sell
65,250
-25,700
-28% -$459K 0.02% 69
2015
Q1 		$1.61M Sell
90,950
-6,100
-6% -$96.4K 0.02% 55
2014
Q4 		$1.29M Buy
97,050
+29,850
+44% +$382K 0.02% 60
2014
Q3 		$794K Hold
67,200
– – 0.01% 71
2014
Q2 		$858K Sell
67,200
-3,096,873
-98% -$40.3M 0.01% 69
2014
Q1 		$42.8M Sell
3,164,073
-6,780,770
-68% -$89M 0.58% 49
2013
Q4 		$120M Sell
9,944,843
-6,264,678
-39% -$74M 1.74% 29
2013
Q3 		$190M Sell
16,209,521
-8,683,284
-35% -$93.9M 3.2% 3
2013
Q2 		$231M Buy
+24,892,805
New +$211M 4.63% 1

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Fairpointe Capital's BSX Position: Q3 2016 in Review

Fairpointe Capital sold out of Boston Scientific (BSX) in Q3 2016, closing a stake of 12,400 shares — an estimated $290K sold.

Fairpointe Capital first reported a position in BSX in Q2 2013 and held it in 13 quarters. The position peaked at $231M in Q2 2013. 566 funds tracked by Wall St. Rank hold BSX as of Q3 2016.

  • Fairpointe Capital reported no remaining Boston Scientific position as of Q3 2016 after selling out during the quarter.
  • Fairpointe Capital sold 12,400 Boston Scientific shares in Q3 2016, an estimated $290K.
  • Fairpointe Capital first reported a position in Boston Scientific in Q2 2013 and held it in 13 quarters.
  • Fairpointe Capital's Boston Scientific position peaked at $231M in Q2 2013.
  • 566 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2016.

Based on Fairpointe Capital's 13F filing for Q3 2016, filed 14 Nov 2016.